The intrauterine devices market size has grown strongly in recent years. It will grow from $3.75 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth observed in the historical period can be attributed to several factors, including family planning initiatives, the empowerment of women, the promotion of long-acting reversible contraception (LARC), the high contraceptive efficacy of intrauterine devices, their cost-effectiveness, the reduction of side effects, and advocacy by healthcare professionals.
The intrauterine devices market size is expected to see steady growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The anticipated growth in the forecast period can be attributed to various factors, including increasing awareness and education, global health initiatives, a shift towards non-hormonal contraceptive options, expanding access to healthcare, the promotion of personalized contraceptive choices, the provision of youth-friendly reproductive services, and integration with primary care services. Major trends expected in the forecast period include the development of frameless IUDs, innovations in biodegradable IUDs, enhancements in user-friendly insertion systems, the integration of contraceptive counseling services, and exploration of non-contraceptive health benefits.
The anticipated rise in the number of unplanned pregnancies is poised to drive the growth of the intrauterine devices market in the coming years. Unplanned pregnancies, characterized as pregnancies that are either unwanted or not intended, occur when individuals do not desire additional children. Intrauterine devices (IUDs) emerge as a highly efficient method of birth control, working by altering the uterine environment to make it less conducive for sperm to fertilize an egg. For instance, data from the United Nations Population Fund in March 2022 highlighted that there are 121 million unintended pregnancies globally each year. Notably, Afghanistan is expected to experience 4.8 million unintended pregnancies by the year 2025. Hence, the increasing prevalence of unplanned pregnancies is a significant driver for the growth of the intrauterine devices market.
The growing number of women in the workforce is also expected to contribute to the expansion of the intrauterine devices market. The term 'women in the workforce' refers to the active participation of women in paid employment across diverse industries and professions. IUDs present working women with a low-maintenance and highly effective contraceptive option, offering long-term protection against unintended pregnancies. For instance, data from the Office for National Statistics in December 2023 indicated that the employment rate for women aged 16 to 64 was 71.9% in 2021, experiencing a slight increase to 72.2% in 2022. Therefore, the rising number of women in the workforce is a driving force behind the growth of the intrauterine devices market.
The expected limited awareness and acceptance of intrauterine devices (IUDs) are likely to impede the growth of the intrauterine devices market in the future. The constrained awareness and acceptance of IUDs have hindered their widespread adoption as a highly effective and reversible contraceptive method, restricting broader reproductive health choices for women. For example, data from NHS Digital in September 2023, a UK-based government agency, revealed that in 2021/22, 55% of females accessing contraception through sexual and reproductive health services utilized Long-Acting Reversible Contraceptives (LARCs), experiencing a 1% decrease from the previous year. Among LARCs, implants were the preferred choice for 22%, followed by intrauterine systems at 16% and intrauterine devices at 10%. Consequently, the limited awareness and acceptance of intrauterine devices are posing a constraint to the growth of the intrauterine devices market.
Prominent companies in the intrauterine devices market are actively involved in developing innovative products, such as IUB Ballerine, to offer women a more effective and convenient form of birth control. IUB Ballerine represents a hormone-free, long-lasting reversible contraceptive made of a flexible nickel/titanium alloy frame with copper beads. These copper beads release copper ions into the uterus, creating an environment hostile to sperm, thereby preventing pregnancy. For instance, in December 2022, Consilient Health Ltd., a UK-based pharmaceutical company, introduced IUB Ballerine, a next-generation intrauterine device designed to be spherical, comfortable, and easy to use. This innovative IUD features a unique three-dimensional ball-such as structure composed of copper beads on a flexible Nitinol frame, minimizing the risk of expulsion and fundal perforation during insertion. It represents a significant advancement in intrauterine contraception, offering improved safety and ease of use over traditional methods.
In December 2022, CooperSurgical Inc., a US-based medical equipment company specializing in manufacturing intrauterine devices (IUDs), entered into a partnership with Ostro, a US-based healthcare technology company. The collaboration between these two companies is geared towards boosting awareness of Paragard as a safe and effective form of contraception. Additionally, the partnership aims to offer women comprehensive information about the various types of IUDs available, with the overarching goal of reducing the stigma associated with IUDs and promoting awareness about pregnancy prevention. This collaborative effort underscores a commitment to advancing reproductive health and ensuring that women have access to accurate information regarding contraceptive options, particularly focusing on the safety and effectiveness of Paragard.
Major companies operating in the intrauterine devices market report are Cardinal Health Inc., Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Perrigo Company plc., CooperSurgical Inc., BIOTRONIK Inc., HLL Lifecare Limited, ANI Pharmaceuticals, Actavis GmbH, DKT International Inc., Nipro Medical Corporation, Pfm medical Inc., Besins HealthCare Limited, Pregna International Limited, SCITECH Medical Inc., Viatris Inc., Medicines360, Afaxys Inc., Access Vascular Inc., OCON Medical Ltd., Agile Therapeutics Inc., SMB Corporation of India, Eurogine S.L.
North America was the largest region in the intrauterine devices market in 2023. The regions covered in the intrauterine devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intrauterine device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Intrauterine devices are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. These devices offer a highly effective and long-lasting method of birth control. Their mechanism involves altering the uterine environment to make it less favorable for sperm to fertilize an egg and, in some cases, affecting the uterine lining to inhibit implantation.
The main types of intrauterine devices include hormonal intrauterine devices and copper intrauterine devices. Hormonal intrauterine devices, often referred to as hormonal IUDs, are contraceptive devices inserted into the uterus for pregnancy prevention. These devices cater to various age groups, such as 15-24 years, 25-34 years, 35-44 years, and those above 44 years. End users of these devices include hospitals, gynecology clinics, community healthcare, and others.
The intrauterine devices market research report is one of a series of new reports that provides intrauterine devices market statistics, including intrauterine devices industry global market size, regional shares, competitors with intrauterine devices market share, detailed intrauterine devices market segments, market trends and opportunities, and any further data you may need to thrive in the intrauterine devices industry. This intrauterine devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intrauterine device market consists of sales of T-shaped frames, frameless IUDs, insertion devices, IUD removal kits, and monofilament strings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The intrauterine devices market size is expected to see steady growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The anticipated growth in the forecast period can be attributed to various factors, including increasing awareness and education, global health initiatives, a shift towards non-hormonal contraceptive options, expanding access to healthcare, the promotion of personalized contraceptive choices, the provision of youth-friendly reproductive services, and integration with primary care services. Major trends expected in the forecast period include the development of frameless IUDs, innovations in biodegradable IUDs, enhancements in user-friendly insertion systems, the integration of contraceptive counseling services, and exploration of non-contraceptive health benefits.
The anticipated rise in the number of unplanned pregnancies is poised to drive the growth of the intrauterine devices market in the coming years. Unplanned pregnancies, characterized as pregnancies that are either unwanted or not intended, occur when individuals do not desire additional children. Intrauterine devices (IUDs) emerge as a highly efficient method of birth control, working by altering the uterine environment to make it less conducive for sperm to fertilize an egg. For instance, data from the United Nations Population Fund in March 2022 highlighted that there are 121 million unintended pregnancies globally each year. Notably, Afghanistan is expected to experience 4.8 million unintended pregnancies by the year 2025. Hence, the increasing prevalence of unplanned pregnancies is a significant driver for the growth of the intrauterine devices market.
The growing number of women in the workforce is also expected to contribute to the expansion of the intrauterine devices market. The term 'women in the workforce' refers to the active participation of women in paid employment across diverse industries and professions. IUDs present working women with a low-maintenance and highly effective contraceptive option, offering long-term protection against unintended pregnancies. For instance, data from the Office for National Statistics in December 2023 indicated that the employment rate for women aged 16 to 64 was 71.9% in 2021, experiencing a slight increase to 72.2% in 2022. Therefore, the rising number of women in the workforce is a driving force behind the growth of the intrauterine devices market.
The expected limited awareness and acceptance of intrauterine devices (IUDs) are likely to impede the growth of the intrauterine devices market in the future. The constrained awareness and acceptance of IUDs have hindered their widespread adoption as a highly effective and reversible contraceptive method, restricting broader reproductive health choices for women. For example, data from NHS Digital in September 2023, a UK-based government agency, revealed that in 2021/22, 55% of females accessing contraception through sexual and reproductive health services utilized Long-Acting Reversible Contraceptives (LARCs), experiencing a 1% decrease from the previous year. Among LARCs, implants were the preferred choice for 22%, followed by intrauterine systems at 16% and intrauterine devices at 10%. Consequently, the limited awareness and acceptance of intrauterine devices are posing a constraint to the growth of the intrauterine devices market.
Prominent companies in the intrauterine devices market are actively involved in developing innovative products, such as IUB Ballerine, to offer women a more effective and convenient form of birth control. IUB Ballerine represents a hormone-free, long-lasting reversible contraceptive made of a flexible nickel/titanium alloy frame with copper beads. These copper beads release copper ions into the uterus, creating an environment hostile to sperm, thereby preventing pregnancy. For instance, in December 2022, Consilient Health Ltd., a UK-based pharmaceutical company, introduced IUB Ballerine, a next-generation intrauterine device designed to be spherical, comfortable, and easy to use. This innovative IUD features a unique three-dimensional ball-such as structure composed of copper beads on a flexible Nitinol frame, minimizing the risk of expulsion and fundal perforation during insertion. It represents a significant advancement in intrauterine contraception, offering improved safety and ease of use over traditional methods.
In December 2022, CooperSurgical Inc., a US-based medical equipment company specializing in manufacturing intrauterine devices (IUDs), entered into a partnership with Ostro, a US-based healthcare technology company. The collaboration between these two companies is geared towards boosting awareness of Paragard as a safe and effective form of contraception. Additionally, the partnership aims to offer women comprehensive information about the various types of IUDs available, with the overarching goal of reducing the stigma associated with IUDs and promoting awareness about pregnancy prevention. This collaborative effort underscores a commitment to advancing reproductive health and ensuring that women have access to accurate information regarding contraceptive options, particularly focusing on the safety and effectiveness of Paragard.
Major companies operating in the intrauterine devices market report are Cardinal Health Inc., Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Perrigo Company plc., CooperSurgical Inc., BIOTRONIK Inc., HLL Lifecare Limited, ANI Pharmaceuticals, Actavis GmbH, DKT International Inc., Nipro Medical Corporation, Pfm medical Inc., Besins HealthCare Limited, Pregna International Limited, SCITECH Medical Inc., Viatris Inc., Medicines360, Afaxys Inc., Access Vascular Inc., OCON Medical Ltd., Agile Therapeutics Inc., SMB Corporation of India, Eurogine S.L.
North America was the largest region in the intrauterine devices market in 2023. The regions covered in the intrauterine devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intrauterine device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Intrauterine devices are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. These devices offer a highly effective and long-lasting method of birth control. Their mechanism involves altering the uterine environment to make it less favorable for sperm to fertilize an egg and, in some cases, affecting the uterine lining to inhibit implantation.
The main types of intrauterine devices include hormonal intrauterine devices and copper intrauterine devices. Hormonal intrauterine devices, often referred to as hormonal IUDs, are contraceptive devices inserted into the uterus for pregnancy prevention. These devices cater to various age groups, such as 15-24 years, 25-34 years, 35-44 years, and those above 44 years. End users of these devices include hospitals, gynecology clinics, community healthcare, and others.
The intrauterine devices market research report is one of a series of new reports that provides intrauterine devices market statistics, including intrauterine devices industry global market size, regional shares, competitors with intrauterine devices market share, detailed intrauterine devices market segments, market trends and opportunities, and any further data you may need to thrive in the intrauterine devices industry. This intrauterine devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intrauterine device market consists of sales of T-shaped frames, frameless IUDs, insertion devices, IUD removal kits, and monofilament strings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Intrauterine Devices Market Characteristics3. Intrauterine Devices Market Trends and Strategies32. Global Intrauterine Devices Market Competitive Benchmarking33. Global Intrauterine Devices Market Competitive Dashboard34. Key Mergers and Acquisitions in the Intrauterine Devices Market
4. Intrauterine Devices Market - Macro Economic Scenario
5. Global Intrauterine Devices Market Size and Growth
6. Intrauterine Devices Market Segmentation
7. Intrauterine Devices Market Regional and Country Analysis
8. Asia-Pacific Intrauterine Devices Market
9. China Intrauterine Devices Market
10. India Intrauterine Devices Market
11. Japan Intrauterine Devices Market
12. Australia Intrauterine Devices Market
13. Indonesia Intrauterine Devices Market
14. South Korea Intrauterine Devices Market
15. Western Europe Intrauterine Devices Market
16. UK Intrauterine Devices Market
17. Germany Intrauterine Devices Market
18. France Intrauterine Devices Market
19. Italy Intrauterine Devices Market
20. Spain Intrauterine Devices Market
21. Eastern Europe Intrauterine Devices Market
22. Russia Intrauterine Devices Market
23. North America Intrauterine Devices Market
24. USA Intrauterine Devices Market
25. Canada Intrauterine Devices Market
26. South America Intrauterine Devices Market
27. Brazil Intrauterine Devices Market
28. Middle East Intrauterine Devices Market
29. Africa Intrauterine Devices Market
30. Intrauterine Devices Market Competitive Landscape and Company Profiles
31. Intrauterine Devices Market Other Major and Innovative Companies
35. Intrauterine Devices Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Intrauterine Devices Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on intrauterine devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for intrauterine devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intrauterine devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Hormonal Intrauterine Device; Copper Intrauterine Device2) By Age Group: 15-24 Years; 25-34 Years; 35-44 Years; Above 44 Years
3) By End-User: Hospitals; Gynecology Clinics; Community Healthcare; Other End Users
Key Companies Mentioned: Cardinal Health Inc.; Pfizer Inc.; Merck and Co. Inc.; AbbVie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Cardinal Health Inc.
- Pfizer Inc.
- Merck and Co. Inc.
- AbbVie Inc.
- Bayer AG
- Abbott Laboratories
- Medtronic plc.
- Teva Pharmaceutical Industries Ltd.
- Boston Scientific Corporation
- Perrigo Company plc.
- CooperSurgical Inc.
- BIOTRONIK Inc.
- HLL Lifecare Limited
- ANI Pharmaceuticals
- Actavis GmbH
- DKT International Inc.
- Nipro Medical Corporation
- Pfm medical Inc.
- Besins HealthCare Limited
- Pregna International Limited
- SCITECH Medical Inc.
- Viatris Inc.
- Medicines360
- Afaxys Inc.
- Access Vascular Inc.
- OCON Medical Ltd.
- Agile Therapeutics Inc.
- SMB Corporation of India
- Eurogine S.L.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | March 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 3.96 Billion |
| Forecasted Market Value ( USD | $ 4.74 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
